Supplementary Figure 1 from The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 1. In vitro combination studies of dinaciclib and other therapeutics against MLL-AF9;NRASG12D leukemia.
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361818735